DIABETES RESEARCH CENTERS

Michael German Michael German MD UCSF UCSF
Dr. German is the Associate Director and Clinical Director of the UCSF Diabetes Center, Director of the the Hillblom Islet Genesis Network and the UCSF NIH Diabetes Research Center (DRC). The UC San Francisco (UCSF) Diabetes Research Center (DRC) is one of only 16 research centers established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to accelerate basic and clinical research into diabetes.
David P Olson David P Olson MD PhD University of Michigan University of Michigan
Using novel mouse models, Dr. Olson is exploring gene expression changes in specific neuronal populations in the brain that are known to be important in regulating energy balance; these studies are directed at examining the link between gene expression in specific areas of the brain and altered metabolism. The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
William Herman William Herman MD University of Michigan University of Michigan
Dr. William Herman received his medical degree from Boston University in 1979. He completed an internship and residency in Internal Medicine at the University of Michigan. Dr Herman's past and present research has focused on clinical, epidemiologic, and health services research in diabetes. The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
Graeme Bell Graeme Bell PhD University of Chicago University of Chicago
Dr. Bell’s research focuses on the genetics of diabetes mellitus. Ongoing studies in his laboratory include the genetics of type 2 diabetes in the Mexican American population of Starr County, Texas. The University of Chicago Diabetes Research and Training Center (DRTC) provides resources for the support and coordination of the research and training activities in diabetes and related metabolic and endocrine disorders of a large and growing number of independently funded but highly interactive investigators.
Raimund I Herzog Raimund I Herzog MD MHS Yale University Yale University
Dr. Herzog’s laboratory is focused on characterizing and preventing its central nervous complications. He uses state-of-the-art technologies to define the impact of diabetes and intensive insulin treatment on brain metabolism and cognition. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Christin Carter-Su Christin Carter-Su PhD University of Michigan University of Michigan
A major and longstanding interest of our laboratory is the delineation of the cellular and molecular mechanisms by which growth hormone (GH) regulates body growth and metabolism. The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
Jerrold M Olefsky MD UCSD-UCLA UCSD-UCLA
My research program is divided into clinical investigation and basic research components. The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
Mitchell A Lazar MD PhD University of Pennsylvania University of Pennsylvania
The Lazar laboratory is studying the transcriptional regulation of metabolism. We are particularly focused on the role played by nuclear receptors. The Penn Diabetes Research Center participates in the nationwide inter-disciplinary program established over forty years ago by the NIDDK to foster research and training in the areas of diabetes and related endocrine and metabolic disorders.
Ian Sweet Ian Sweet PhD University of Washington University of Washington
Dr. Sweet’s research focuses on regulation and impairment of insulin secretion in Type 2 Diabetes; pancreatic beta cell death; metabolic basis of inflammation and T cell calcium metabolism in Type 1 Diabetes. The University of Washington (UW) Diabetes Research Center (DRC) at the University of Washington is one of 16 Diabetes Research Centers sponsored by the National Institutes of Health to promote basic, translational, and clinical research on diabetes and related metabolic disorders.
Joel Habener Joel Habener MD Boston Area Boston Area
Dr. Habener is Professor of Medicine at Harvard Medical School and Associate Physician and Chief of the Laboratory of Molecular Endocrinology at Massachusetts General Hospital, Boston. The Boston Area Diabetes Endocrinology Research Center is a consortium of laboratory-based and clinical investigators whose efforts are directed toward addressing many of the major research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes.
Robert Stanley Sherwin Robert Stanley Sherwin MD Yale University Yale University
Dr. Sherwin's special clinical interests include patients with type 1 diabetes, intensified insulin therapy, complicated type 2 diabetes patients, and hypoglycemia associated with diabetes. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Clay F Semenkovich Clay F Semenkovich MD Washington University in St Louis Washington University in St Louis
Clay F. Semenkovich, M.D., is Chief of the Division of Endocrinology, Metabolism and Lipid Research and Professor of Medicine and of Cell Biology and Physiology. TThe mission of the Washington University School of Medicine (WUSM) Diabetes Research Center (DRC) is to support and enhance research in diabetes and related metabolic diseases.
Rudolph Leibel MD Columbia University Columbia University
Dr. Leibel's research focuses on the genetics of obesity and non-insulin dependent diabetes. His laboratory has mapped, cloned and identified mutations in the obese and fatty genes in rats, mice, and more recently in humans. The Columbia University Diabetes and Endocrinology Research Center provides research support for investigators pursuing research on diabetes and metabolic disorders.
Julian P Whitelegge Julian P Whitelegge PhD UCSD-UCLA UCSD-UCLA
Julian Whitelegge received his Ph.D. from Imperial College of Science and Technology, University of London in 1989 and became heavily involved in mass spectrometry research in the mid nineties. The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
Kevan Herold Kevan Herold MD Yale University Yale University
My background and research are in translational immunology. I am interested in understanding the basis for autoimmune diseases and developing new therapies based on our understanding of disease mechanisms. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Lori Laffel Lori Laffel MD MPH Joslin Diabetes Center Joslin Diabetes Center
Dr. Laffel focuses her research and clinical interests on preventing the late complications of type 1 diabetes and preserving the health, normal growth, development and family functioning of children, adolescents and young adults with diabetes. Since its inception in 1898, the primary mission of the Joslin Diabetes Center has been to care for people with diabetes, and conduct research to provide new knowledge about diabetes and its complications that will lead to new treatments, prevention and/or cure of these disorders.

Diabetes Centers Overview

Diabetes Centers

NIDDK Diabetes Centers

The NIDDK-supported Diabetes Research Centers (DRCs) are part of an integrated program of diabetes and related endocrinology and metabolism research. NIDDK’s Diabetes Centers program supports extramural research institutions that have established an existing base of high-quality, diabetes-related research. Centers provide increased, cost effective collaboration among multidisciplinary groups of investigators at institutions with an established, comprehensive research base in diabetes and related areas of endocrinology and metabolism. DRCs are intended to improve the quality and multidisciplinary nature of research on diabetes by providing shared access to specialized technical resources and expertise. DRCs are intended to facilitate progress in research with the goal of developing new methods to treat, prevent and ultimately cure diabetes mellitus and its complications.

In the Spotlight

Pilot & Feasibility Study
Center Publication
NIDDK Center
The Centers for Diabetes Translation Research are part of an integrated program whose cores support and enhance diabetes type II translation research (e.g. bedside to practice and the community, dissemination and implementation science).
Diabetes Resource
The purpose of this randomized clinical trial is to evaluate the efficacy and safety of the alpha adrenergic blocker Alfuzosin (Uroxatral) in men with relatively new onset of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).